Semnur Pharmaceuticals, Inc.
SMNRNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SMNR. That does not mean none is planned.
Get an email about SMNR's next catalysts
Track Semnur Pharmaceuticals (SMNR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SP-102 | Phase 2 | Lumbosacral Radicular Pain | - | - |
Frequently asked questions
What is in Semnur Pharmaceuticals, Inc.'s drug pipeline?β
CatalystAlert tracks 1 drug candidate in Semnur Pharmaceuticals, Inc.'s (SMNR) pipeline across Phase 2. Its lead program is SP-102 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Semnur Pharmaceuticals, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Semnur Pharmaceuticals, Inc. (SMNR) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track SMNR biotech catalysts?β
Add SMNR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Semnur Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
